Detalhe da pesquisa
1.
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016.
Gynecol Oncol
; 186: 61-68, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603953
2.
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.
N Engl J Med
; 380(24): 2317-2326, 2019 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189035
3.
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
N Engl J Med
; 381(25): 2403-2415, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562800
4.
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study.
Gynecol Oncol
; 164(2): 428-436, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34903380
5.
Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 159(1): 79-87, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723679
6.
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.
N Engl J Med
; 374(8): 738-48, 2016 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26933849
7.
Shaping the standard of care in ovarian cancer management: A review of Gynecologic Oncology Group (GOG)/NRG oncology clinical trials of the past twenty years.
Gynecol Oncol
; 153(3): 479-486, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30905435
8.
Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?
Gynecol Oncol
; 154(1): 150-155, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30992143
9.
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.
Gynecol Oncol
; 148(1): 174-180, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132872
10.
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 145(2): 366-373, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28314589
11.
A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 145(2): 236-242, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341300
12.
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.
Gynecol Oncol
; 145(3): 519-525, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28392124
13.
A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 140(2): 204-9, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26616225
14.
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.
Gynecol Oncol
; 143(2): 294-301, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27542967
15.
An Isolated Metastasis From Clear Cell Renal Cell Carcinoma to the Uterus: A Case Report and Review of Literature.
Int J Gynecol Pathol
; 35(5): 419-22, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26630224
16.
Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice.
Gynecol Oncol
; 138(3): 712-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26177553
17.
Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone.
Gynecol Oncol
; 133(3): 416-20, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24631445
18.
A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study.
Gynecol Oncol
; 133(3): 537-41, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24594074
19.
A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
; 125(2): 367-71, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22366594
20.
A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
; 127(3): 506-10, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22943879